Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Magnetic Resonance Spectroscopy (MRS) Market by Product (Low, Medium, High) and by Application (Brain Neurological, Spine Musculoskeletal, Vascular, Abdominal Pelvic, Cardiac, Breast): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03308

Pages: NA

Charts: NA

Tables: NA

Magnetic resonance spectroscopy (MRS) is an ionization radiation-free analytical technique associated with imaging method, which can be further utilized for deducing information related to cellular activity. It can be employed in a noninvasive imaging method having the ability to scan and reveal the shape and size of tumor.

The growth of the global magnetic resonance spectroscopy market is driven by increase in prevalence of diseases and rise in concern towards patient health. Furthermore, technological advancement and development in medical devices is expected to boost the market growth. However, high cost of devices and dearth of experienced medical professionals impede the market growth.

The global magnetic resonance spectroscopy market is segmented on the basis of product, application, and geography. Based on product, the market is divided into low, high, and medium. By application, it is categorized into brain & neurological, spine & musculoskeletal, vascular, abdominal & pelvic, cardiac, and breast. Geographically, it is analyzed across North America, Europe, Asia Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and subsegment.

Comprehensive competitive analysis and profiles of the major market players such as GE Healthcare, Siemens AG, Koninklijke Philips N.V., Hitachi Medical Systems America, Inc., Toshiba Corporation, Aurora Imaging Technologies, Inc., Esaote SpA, and Sanrad Medical Systems Pvt. Ltd. are provided in this report.

Key Benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
  • It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

 Key Market Segments

  • By Product
    • Low
    • Medium
    • High
  • By Application
    • Brain & Neurological
    • Spine & Musculoskeletal
    • Vascular
    • Abdominal & Pelvic
    • Cardiac
    • Breast
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Sanrad Medical Systems Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
  • Oxford Instruments plc
  • Esaote SpA
  • Hitachi Medical Systems America, Inc.
  • GE Healthcare
  • Toshiba Corporation
  • Aurora Imaging Technologies, Inc.
  • Siemens AG
  • Koninklijke Philips N.V.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Low

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Medium

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. High

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Brain And Neurological

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Spine And Musculoskeletal

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Vascular

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Abdominal And Pelvic

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Cardiac

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Breast

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Magnetic Resonance Spectroscopy (mrs) Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Magnetic Resonance Spectroscopy (mrs) Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Magnetic Resonance Spectroscopy (mrs) Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Magnetic Resonance Spectroscopy (mrs) Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Magnetic Resonance Spectroscopy (mrs) Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Magnetic Resonance Spectroscopy (mrs) Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. GE Healthcare

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Siemens AG

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Koninklijke Philips N.V.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Hitachi Medical Systems America, Inc.

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Toshiba Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Aurora Imaging Technologies, Inc.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Esaote SpA

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Sanrad Medical Systems Pvt. Ltd.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Thermo Fisher Scientific Inc.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Oxford Instruments Plc

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR LOW, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR MEDIUM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR HIGH, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR BRAIN AND NEUROLOGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR SPINE AND MUSCULOSKELETAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR VASCULAR, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR ABDOMINAL AND PELVIC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR CARDIAC, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR BREAST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 16. U.S. MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. U.S. MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. CANADA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. CANADA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. MEXICO MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. FRANCE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. FRANCE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. GERMANY MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. GERMANY MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. ITALY MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. ITALY MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. SPAIN MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. SPAIN MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. UK MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. UK MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. RUSSIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. RUSSIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. REST OF EUROPE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. REST OF EUROPE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. CHINA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. CHINA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. JAPAN MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. JAPAN MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. INDIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. INDIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. SOUTH KOREA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. SOUTH KOREA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. AUSTRALIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. AUSTRALIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. THAILAND MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. THAILAND MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. MALAYSIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. MALAYSIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. INDONESIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 57. INDONESIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY REGION, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. BRAZIL MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. BRAZIL MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH AFRICA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH AFRICA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SAUDI ARABIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. SAUDI ARABIA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. UAE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. UAE MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. ARGENTINA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. ARGENTINA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. REST OF LAMEA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 74. REST OF LAMEA MAGNETIC RESONANCE SPECTROSCOPY (MRS), BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 76. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 77. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 78. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 79. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. SIEMENS AG: KEY EXECUTIVES
  • TABLE 81. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 82. SIEMENS AG: OPERATING SEGMENTS
  • TABLE 83. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 84. SIEMENS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 86. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 87. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
  • TABLE 88. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 89. KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. HITACHI MEDICAL SYSTEMS AMERICA, INC.: KEY EXECUTIVES
  • TABLE 91. HITACHI MEDICAL SYSTEMS AMERICA, INC.: COMPANY SNAPSHOT
  • TABLE 92. HITACHI MEDICAL SYSTEMS AMERICA, INC.: OPERATING SEGMENTS
  • TABLE 93. HITACHI MEDICAL SYSTEMS AMERICA, INC.: PRODUCT PORTFOLIO
  • TABLE 94. HITACHI MEDICAL SYSTEMS AMERICA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. TOSHIBA CORPORATION: KEY EXECUTIVES
  • TABLE 96. TOSHIBA CORPORATION: COMPANY SNAPSHOT
  • TABLE 97. TOSHIBA CORPORATION: OPERATING SEGMENTS
  • TABLE 98. TOSHIBA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 99. TOSHIBA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. AURORA IMAGING TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 101. AURORA IMAGING TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 102. AURORA IMAGING TECHNOLOGIES, INC.: OPERATING SEGMENTS
  • TABLE 103. AURORA IMAGING TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 104. AURORA IMAGING TECHNOLOGIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. ESAOTE SPA: KEY EXECUTIVES
  • TABLE 106. ESAOTE SPA: COMPANY SNAPSHOT
  • TABLE 107. ESAOTE SPA: OPERATING SEGMENTS
  • TABLE 108. ESAOTE SPA: PRODUCT PORTFOLIO
  • TABLE 109. ESAOTE SPA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. SANRAD MEDICAL SYSTEMS PVT. LTD.: KEY EXECUTIVES
  • TABLE 111. SANRAD MEDICAL SYSTEMS PVT. LTD.: COMPANY SNAPSHOT
  • TABLE 112. SANRAD MEDICAL SYSTEMS PVT. LTD.: OPERATING SEGMENTS
  • TABLE 113. SANRAD MEDICAL SYSTEMS PVT. LTD.: PRODUCT PORTFOLIO
  • TABLE 114. SANRAD MEDICAL SYSTEMS PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 116. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 117. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 118. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 119. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. OXFORD INSTRUMENTS PLC: KEY EXECUTIVES
  • TABLE 121. OXFORD INSTRUMENTS PLC: COMPANY SNAPSHOT
  • TABLE 122. OXFORD INSTRUMENTS PLC: OPERATING SEGMENTS
  • TABLE 123. OXFORD INSTRUMENTS PLC: PRODUCT PORTFOLIO
  • TABLE 124. OXFORD INSTRUMENTS PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET
  • FIGURE 3. SEGMENTATION MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET
  • FIGURE 11. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR LOW, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR MEDIUM, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR HIGH, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR BRAIN AND NEUROLOGICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR SPINE AND MUSCULOSKELETAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR VASCULAR, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR ABDOMINAL AND PELVIC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR CARDIAC, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET FOR BREAST, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: MAGNETIC RESONANCE SPECTROSCOPY (MRS) MARKET
  • FIGURE 28. TOP PLAYER POSITIONING, 2024
  • FIGURE 29. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. SIEMENS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. SIEMENS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. SIEMENS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. KONINKLIJKE PHILIPS N.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. HITACHI MEDICAL SYSTEMS AMERICA, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. HITACHI MEDICAL SYSTEMS AMERICA, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. HITACHI MEDICAL SYSTEMS AMERICA, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. TOSHIBA CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. TOSHIBA CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. TOSHIBA CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. AURORA IMAGING TECHNOLOGIES, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. AURORA IMAGING TECHNOLOGIES, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. AURORA IMAGING TECHNOLOGIES, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. ESAOTE SPA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. ESAOTE SPA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. ESAOTE SPA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. SANRAD MEDICAL SYSTEMS PVT. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. SANRAD MEDICAL SYSTEMS PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. SANRAD MEDICAL SYSTEMS PVT. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. OXFORD INSTRUMENTS PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. OXFORD INSTRUMENTS PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. OXFORD INSTRUMENTS PLC: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Magnetic Resonance Spectroscopy (MRS) Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved